{
    "root": "27a10706-f06f-407c-ae22-9a49d6a543e8",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Olanzapine",
    "value": "20250221",
    "ingredients": [
        {
            "name": "OLANZAPINE",
            "code": "N7U69T4SZR",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7735"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "TARTARIC ACID",
            "code": "W4888I119H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        }
    ],
    "indications": {
        "text": "olanzapine injection atypical antipsychotic indicated : \u2022 treatment acute agitation associated schizophrenia bipolar mania . ( 1.4 ) \u2022 efficacy established three 1-day trials adults . ( 14.3 )",
        "doid_entities": [
            {
                "text": "schizophrenia (DOID:5419)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5419"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute agitation associated",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_454831"
            }
        ]
    },
    "contraindications": {
        "text": "agitation associated schizophrenia bipolar mania adults ( 2.4 ) im : 10 mg ( 5 mg 7.5 mg clinically warranted ) assess orthostatic hypotension prior subsequent dosing ( max . 3 doses 2 4 hrs apart )",
        "doid_entities": [
            {
                "text": "schizophrenia (DOID:5419)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5419"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": null,
    "adverseReactions": "\u2022none olanzapine injection monotherapy . \u2022for information lithium valproate , refer section package inserts products .",
    "indications_original": "Olanzapine for injection is an atypical antipsychotic indicated: \u2022 Treatment of acute agitation associated with schizophrenia and bipolar I mania. ( 1.4 ) \u2022 Efficacy was established in three 1-day trials in adults. ( 14.3 )",
    "contraindications_original": "Agitation associated with Schizophrenia and Bipolar I Mania in adults ( 2.4 ) IM: 10 mg (5 mg or 7.5 mg when clinically warranted) Assess for orthostatic hypotension prior to subsequent dosing (max. 3 doses 2 to 4 hrs apart)",
    "adverseReactions_original": "\u2022None with olanzapine for injection monotherapy.\n                     \n                        \u2022For specific information about the contraindications of lithium or valproate, refer to the Contraindications section of the package inserts for these other products.",
    "drug": [
        {
            "name": "Olanzapine",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7735"
        }
    ]
}